Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-866,087 in alcohol dependence
NCT00147576Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CP-866087 in alcohol dependence (5 arms), sponsored by Pfizer. Primary endpoint: Total number of standardized drinks consumed during a two-hour laboratory-based self-administration procedure at 7 days. Started Dec 2003; status: completed.
02
Drugs
CP-866087
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00147576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147576.